The Indian Government’s recent announcement about the establishment of a National Genomic Grid (NGG) signals a significant advancement in cancer research. This novel initiative will study the genomic data of Indian cancer patients, contributing to a broader understanding of the disease and paving the way for the development of more effective treatments.
What is the National Genomic Grid (NGG)?
The newly announced NGG is a large-scale project devoted to collecting samples from cancer patients throughout India. The collection process is set to be carried out via a network of pan-Indian collection centres, which will collaborate with all cancer treatment institutions in the country. NGG’s operation will align with the framework established by the National Cancer Tissue Biobank (NCTB), currently hosted at the Indian Institute of Technology, Madras.
National Cancer Tissue Biobank: A Joint Initiative
The National Cancer Tissue Biobank is a joint initiative between the Department of Science and Technology (DST), Government of India, and the Indian Institute of Technology, Madras. The biobank is responsible for collecting cancer tissue samples from consenting patients who have been diagnosed with the disease. The primary objective of this initiative is to provide researchers with high-quality cancer tissues and corresponding patient data. This then facilitates robust cancer research, contributing to the development of improved diagnostic tools and treatments for the condition.
Role of Genome Sequencing
The research conducted through NCTB involves an advanced technique known as Genome Sequencing. By studying the sequence of genes, scientists can gain valuable insight into different types of cancers and their behaviours. This information is integral to the process of creating more effective therapies and treatment plans.
| Initiative | Collaborating Institutions | Primary Objective |
|---|---|---|
| National Genomic Grid | Various cancer treatment institutions across India | Collect and study genomic data of Indian cancer patients |
| National Cancer Tissue Biobank | Department of Science and Technology, Government of India and Indian Institute of Technology, Madras | Provide high-quality cancer tissues for research |
Genome India Initiative: Aiming High
In addition to the NGG and NCTB, the government has also launched the Genome India Initiative. This ambitious project aims to scan 20,000 Indian genomes over the next five years, with the ultimate goal of developing diagnostic tests and effective therapies for diseases such as cancer.
The Impact of the National Genomic Grid
Through the establishment of the National Genomic Grid, the government aims to accelerate cancer research, making treatment accessible to individuals from various economic backgrounds. NGG will play a critical role in understanding the genomic factors influencing cancer and in identifying the suitable treatment modalities for the Indian population.
Last Modified: February 6, 2024